Trial Profile
A Long Term, Open-Label, Multi-Center Study Evaluating Safety and Tolerability of Oxycodone in Patients With Moderate to Severe Cancer Pain
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Mar 2020
Price :
$35
*
At a glance
- Drugs Oxycodone (Primary)
- Indications Cancer pain
- Focus Adverse reactions
- Acronyms STOP pain
- Sponsors Taiwan Mundipharma Pharmaceuticals
- 16 Mar 2020 Status changed from recruiting to completed.
- 08 Jun 2017 New trial record